Today's Highlights
1. Shanghai Awinic Technology Co.,Ltd. (688798.SH): The company announced it is planning to acquire equity in Yutai Semiconductor Co., Ltd. through the issuance of shares and cash payment while raising matching funds, which upon preliminary calculation may constitute a major asset restructuring. This will not result in a change of actual controller and does not constitute a restructuring listing. Due to the uncertainty of the matter, the company's shares and convertible bonds "Awinic Convertible Bonds" will be suspended from trading and conversion starting from the market opening on November 10, 2026, with an expected suspension period of no more than 10 trading days.
2. Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ): The seller will divest 64.48% equity in Frontage Holdings, retaining domestic business and spinning off overseas laboratories. The company announced that its wholly-owned subsidiary Hong Kong Tigermed, CRL, and a trust related to Dr. Li Song jointly established SanRex to privatize Hong Kong-listed controlling subsidiary Frontage Holdings through a scheme of arrangement, with a simultaneous spin-off: the target business has an initial transaction price of US$470 million, the overseas non-target business is US$84.4 million, and the domestic non-target business is US$205.5 million. Prior to the transaction, the company held a total of 64.48% of Frontage Holdings, and after completion will no longer hold any shares and will only retain the domestic non-target business. During the privatization phase, the company can receive cash consideration of HK$535.67 million (approximately RMB 461.2 million) corresponding to the cancellation of 11.09% of shares. This transaction is expected to generate profit accounting for more than 50% of the audited net profit of the most recent fiscal year and still requires shareholder meeting approval.
3. Tech-Bank Food Co.,Ltd. (002124.SZ): Tongwei Group was selected as the industrial investor, acquiring 1.47 billion shares of conversion capital increase for RMB 1.441 billion. The company announced that after comprehensive assessment by the investor review committee, Tongwei Group Co., Ltd. was confirmed as the selected industrial investor and a "Restructuring Investment Agreement" was signed. Based on the existing total share capital, a capital reserve conversion of 13.8 shares for every 10 shares will be implemented, totaling 3,066,268,688 new shares, of which Tongwei Group will conditionally receive 1,470,120,300 shares, paying investment funds of RMB 1.441 billion at a price of RMB 0.98 per share, with the remaining converted shares used to settle bankruptcy claims. The Ningbo Intermediate Court has approved an extension of the pre-restructuring period to May 9, 2027. If the court rules to accept the restructuring, the stock will be subject to delisting risk warning, and there remains the risk of bankruptcy declaration and stock termination of listing if the restructuring fails.
4. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH): Guangzhou Pharmaceutical is listing to attract strategic investors, raising no more than RMB 6 billion and reducing its stake to 53.23%. The company announced that its controlling subsidiary Guangzhou Pharmaceutical Co., Ltd. plans to publicly list on the Guangzhou Property Exchange to introduce strategic investors and implement a targeted share issuance, planning to solicit no more than 15 investors, with an issuance price of no less than RMB 3.46 per share, targeted issuance of no more than 1,734,104,046 shares, and a fundraising scale of no more than RMB 6 billion. The company does not enjoy preemptive subscription rights. After the capital increase is completed, the company is expected to hold no less than 53.23% and remain the controlling shareholder, with the consolidated statement scope unchanged. This matter still requires shareholder meeting approval, and there is uncertainty as to whether investors can be successfully introduced and the final fundraising amount.
5. Chengdu Sheng Nuo Biotec Co.,Ltd. (688117.SH): Customer returns and refunds of US$24.9596 million are expected to reduce net profit attributable to the parent by RMB 84.2466 million. The company announced that the company and its wholly-owned subsidiary Sheng Nuo Pharmaceutical signed a "Return and Refund Agreement" with US customer A, agreeing to return part of the peptide API under two purchase orders dated February 6, 2025 and November 24, 2025, with the company refunding the total purchase price of US$24.9596 million in installments in US dollars. After the refund according to the agreement, it is expected to reduce the main business revenue of this year by RMB 163.2411 million, total profit by RMB 99.1137 million, and net profit attributable to the parent by RMB 84.2466 million, without involving adjustments to accounting data for the first three quarters of 2026 and prior years. The company's revenue for the first three quarters was RMB 741.2052 million, and net profit attributable to the parent was RMB 170.5896 million.
6. Beijing Huaru Technology Co.,Ltd. (301302.SZ): Banned from participating in military materials and engineering service procurement activities for 5 years. The company announced that it received the "Prohibitive Handling Regarding Beijing Huaru Technology Co., Ltd." issued by the Military Procurement Network. This handling is in response to the suspension matter of March 31, 2026, and the result is a ban on the company from participating in military materials and engineering service procurement activities from November 22, 2023 to November 22, 2028, with the effective scope covering the entire military and the effective category being all categories of projects. Legal representative Han Chao is simultaneously banned from March 31, 2026 to March 31, 2029. The main violation is "other, according to relevant department notifications, there are violations."
7. Pinlive Foods Co.,Ltd. (300892.SZ): The consortium has been confirmed as the restructuring investor of Taishan Beer, which may constitute a major asset restructuring. The company announced that the consortium formed by the company and Tai'an Zhiyi Culture Investment Partnership and Tai'an Xinyi Culture Investment Partnership has been confirmed as the restructuring investor of Shandong Taishan Beer Co., Ltd. Taishan Beer and four affiliated companies including Tai'an Taishan Beer Logistics and Foshan Taishan Beer were ruled on April 23, 2026 by the Tai'an Taishan District People's Court for substantive consolidated bankruptcy restructuring. Subsequently, it is still necessary to reach agreement with creditors on the restructuring plan and obtain court approval. This investment may carry the risk of constituting a major asset restructuring.
Operating Results
1. Daqin Railway (601006.SH): October Daqin Line cargo transport volume was 32.02 million tons, a year-on-year decrease of 1.51%. The company announced that the average daily transport volume was 1.0329 million tons, with a cumulative total of 329.59 million tons from January to October, a year-on-year increase of 3.52%.
2. Shennong Group (605296.SH): October sales of commercial pigs were 428,400 heads, with revenue of RMB 591 million. The company announced that sales volume increased by 55.90% year-on-year and revenue increased by 49.24% year-on-year, with an average price of RMB 9.83 per kilogram.
3. New Wufeng (600975.SH): October sales of live pigs were 384,700 heads, a year-on-year decrease of 36.93%. The company announced that among them, commercial pigs were 180,000 heads, with a commercial pig sales price of RMB 9.69 per kilogram.
Buybacks & Shareholding Changes
1. WUS Printed Circuit (002463.SZ): Plans to repurchase RMB 500 million to RMB 1 billion, with the actual controller simultaneously increasing holdings by RMB 20 million to RMB 30 million. The company announced that the repurchase price will not exceed RMB 156.70 per share, and Hefei Youlian will increase holdings within 6 months.
2. AMEC (688012.SH): First repurchase of 79,600 shares, with a transaction amount of RMB 19.9856 million. The company announced that the transaction price ranged from RMB 247.51 to RMB 257.00 per share, with a total plan of RMB 400 million to RMB 500 million.
3. Tinci Material (002709.SZ): Controlling shareholder and Chairman Xu Jinfu proposed a repurchase of RMB 50 million to RMB 100 million. The company announced that the price will not exceed 150% of the average price of the previous 30 trading days, to be used for incentives or cancellation.
4. Shengyi Electronics (688183.SH): Shareholder Dongguan Science and Technology Innovation Investment Group plans to increase holdings by RMB 50 million to RMB 100 million. The company announced that before the increase, it held a total of 7.73% with concert parties, to be implemented within 6 months.
Major Contracts
1. Traffic Control Technology (688015.SH): Won the bid for the Shuohuang Railway locomotive moving block transformation project, with an amount of RMB 154.2 million. The company announced that it has received the bid-winning notice but has not yet signed a formal contract, with a delivery period of 90 days.
2. Chongqing Construction Engineering (600939.SH): The consortium won the bid for the Wansheng Economic Development Zone EPC project, with a bid price of approximately RMB 494 million. The company announced that it is the consortium leader, with a construction volume of approximately RMB 490 million and a construction period of 730 days.
Comments